Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Inhibition of Human Natural Killer (NK) Cell-mediated Cytotoxi- city against Porcine Endothelial Cells (EC). (zu SCORE B)
Seebach Jörg Dieter University of Zurich - ZH 01.03.1998 31.10.2001 Project funding

Molecular Mechanisms and Inhibition of Human Innate Immune Responses against Porcine Endothelial Cells
Seebach Jörg Dieter University of Zurich - ZH 01.01.2006 31.12.2010 Project funding

Transgenic strategies to overcome cellular rejection in pig-to-human xenotransplantation
Seebach Jörg Dieter University of Geneva - GE 01.04.2012 31.07.2015 Project funding

Molecular Mechanisms and Inhibition of Human Cell-Mediated Immune Response against Porcine Endothelial Cells.
Seebach Jörg Dieter University of Zurich - ZH 01.06.2002 31.05.2005 Project funding

Antibody-dependent innate immune cell functions in autoimmunity and monoclonal antibody therapies
Seebach Jörg Dieter University of Geneva - GE 01.10.2021 30.09.2025 Project funding

ABO-incompatibility and hyperacute xenograft rejection
Seebach Jörg Dieter University of Zurich - ZH 01.10.2000 30.09.2005 NRP 46 Implants and Transplants

Strategies to promote tolerance and reduce rejection in rat-to-mouse xenotransplantation models
Seebach Jörg Dieter University of Geneva - GE 01.06.2015 31.05.2018 Project funding

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Characterisation and evaluation of cell phenotype and extracellular matrix in tissue engineering heart valves based on human cardio-vascular cells
Hoerstrup Simon Philipp University of Zurich - ZH 01.06.2003 31.05.2005 NRP 46 Implants and Transplants

Ischemia-Reperfusion Injury in Cardiac Surgery.
Zünd Gregor University of Zurich - ZH 01.09.1999 31.12.2004 Project funding

Xeno2Cure - advanced engineering and testing of organ donor pigs
Rieben Robert University of Berne - BE 01.04.2021 31.03.2025 Sinergia

-